PT90095A - Processo para a preparacao de derivados de 2,2'-iminobisetanol destiandos a potenciacao dos efeitos de agentes redutores da pressao sanguinea - Google Patents

Processo para a preparacao de derivados de 2,2'-iminobisetanol destiandos a potenciacao dos efeitos de agentes redutores da pressao sanguinea

Info

Publication number
PT90095A
PT90095A PT90095A PT9009589A PT90095A PT 90095 A PT90095 A PT 90095A PT 90095 A PT90095 A PT 90095A PT 9009589 A PT9009589 A PT 9009589A PT 90095 A PT90095 A PT 90095A
Authority
PT
Portugal
Prior art keywords
iminobisetanol
sanguine
potentiation
preparation
effects
Prior art date
Application number
PT90095A
Other languages
English (en)
Other versions
PT90095B (pt
Inventor
Guy Rosalia Eugene Van Lommen
Raymond Methieu Xhonneux
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22629045&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PT90095(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Publication of PT90095A publication Critical patent/PT90095A/pt
Publication of PT90095B publication Critical patent/PT90095B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
PT90095A 1988-03-23 1989-03-22 Processo para a preparacao de derivados de 2,2'-iminobisetanol destiandos a potenciacao dos efeitos de agentes redutores da pressao sanguinea PT90095B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US17274788A 1988-03-23 1988-03-23

Publications (2)

Publication Number Publication Date
PT90095A true PT90095A (pt) 1989-11-10
PT90095B PT90095B (pt) 1994-11-30

Family

ID=22629045

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90095A PT90095B (pt) 1988-03-23 1989-03-22 Processo para a preparacao de derivados de 2,2'-iminobisetanol destiandos a potenciacao dos efeitos de agentes redutores da pressao sanguinea

Country Status (19)

Country Link
EP (1) EP0334429B1 (pt)
JP (1) JPH0637487B2 (pt)
KR (1) KR970011287B1 (pt)
AU (1) AU621591B2 (pt)
CA (1) CA1337432C (pt)
CY (1) CY1802A (pt)
DE (2) DE19675037I1 (pt)
DK (1) DK174422B1 (pt)
ES (1) ES2052881T3 (pt)
GR (1) GR3006972T3 (pt)
HK (1) HK123594A (pt)
HU (1) HU211539A9 (pt)
IE (1) IE62159B1 (pt)
IL (1) IL89691A (pt)
LU (1) LU88842I2 (pt)
NL (1) NL950031I2 (pt)
NZ (1) NZ228321A (pt)
PT (1) PT90095B (pt)
ZA (1) ZA892179B (pt)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4135474A1 (de) * 1991-10-28 1993-04-29 Bayer Ag 2-aminomethyl-chromane
TW355683B (en) * 1994-02-17 1999-04-11 Janssen Pharmaceutica Nv Composition containing micronized nebivolol
CA2207333C (en) * 1994-12-28 2006-10-17 Janssen Pharmaceutica, Naamloze Vennootschap Use of nebivolol as an anti-atherogenic
US5541199A (en) * 1995-06-02 1996-07-30 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5663194A (en) * 1995-07-25 1997-09-02 Mewshaw; Richard E. Chroman-2-ylmethylamino derivatives
US5684039A (en) * 1995-07-25 1997-11-04 American Home Products Corporation Chroman-2-ylmethylamino derivatives
US5670667A (en) * 1995-07-25 1997-09-23 American Home Products Corporation Chroman-2-ylmethylamino derivatives
ATE457169T1 (de) 1998-10-15 2010-02-15 Imp Innovations Ltd Verbindungen für die behandlung von gewichtsverlust
DE60233140D1 (de) 2001-05-02 2009-09-10 Nitromed Inc Nitrosiertes und nitrosyliertes nebivolol und seine metaboliten, zusammensetzungen und anwendungsverfahren
RU2378272C2 (ru) 2004-07-30 2010-01-10 Торрент Фармасьютикалз Лимитед Небиволол и его фармацевтически приемлемые соли, способ их получения и фармацевтические композиции небиволола
ATE465157T1 (de) * 2004-08-11 2010-05-15 Hetero Drugs Ltd Neues verfahren zur herstellung von nebivololzwischenprodukten
CN100341866C (zh) * 2004-08-30 2007-10-10 中国科学院理化技术研究所 α，α’－[亚氨基二（亚甲基）]－双－（6－氟－3，4－二氢－2H－1－苯并吡喃－2－甲醇）甲烷磺酸盐的合成方法
US20070014734A1 (en) * 2005-01-31 2007-01-18 O'donnell John P Glucuronidated nebivolol metabolites
JP2008528626A (ja) * 2005-01-31 2008-07-31 マイラン ラボラトリーズ インク． ヒドロキシル化されたネビボロールを含む薬学的組成物
CN100546987C (zh) * 2005-03-03 2009-10-07 浙江医药股份有限公司新昌制药厂 Dl-奈必洛尔及其盐酸盐的制备方法
US7560575B2 (en) 2005-12-28 2009-07-14 Acino Pharma Ag Process for preparation of racemic Nebivolol
EP1803716B1 (en) * 2005-12-28 2012-07-25 Acino Pharma AG A process for preparation of racemic nebivolol
WO2007083318A1 (en) 2006-01-18 2007-07-26 Hetero Drugs Limited Process for isolation of desired isomers of nebivolol intermediates
ITMI20061889A1 (it) * 2006-10-03 2008-04-04 Zambon Spa Processo di preparazione di nebivololo
PL2228374T3 (pl) * 2006-11-27 2013-11-29 Zach System Spa Mrówczan nebiwololu
SI2102196T1 (sl) * 2006-11-27 2012-12-31 Zach System S.P.A. Postopek za pripravo nebivolola
GB0624282D0 (en) 2006-12-05 2007-01-10 Cavalla David Treatment of cachexia
WO2008089549A1 (en) 2007-01-22 2008-07-31 Genpharm Ulc Pharmaceutical compositions comprising nebivolol or a nebivolol analogue
CN101463024B (zh) 2007-12-21 2011-06-08 上海现代制药股份有限公司 一种制备rrrs和sssr型的奈必洛尔中间体混合物的方法
CN101531651B (zh) * 2008-03-13 2011-05-04 四川大学 光学活性3,4-二氢-2h-1-苯并吡喃-2-羧酸和3,4-二氢-4-氧-2h-1-苯并吡喃-2-羧酸类化合物的制备方法
ITMI20080547A1 (it) * 2008-03-31 2009-10-01 Zach System Spa Processo di preparazione di nebivololo
IT1395354B1 (it) 2009-07-23 2012-09-14 Zach System Spa Processo di preparazione di nebivololo
DE102010005953A1 (de) 2010-01-27 2011-07-28 Corden PharmaChem GmbH, 68305 Verfahren zur Herstellung von Nebivolol
US8785664B2 (en) 2010-02-11 2014-07-22 Menarini International Operations Luxembourg S.A. Process for the preparation of nebivolol
IT1397962B1 (it) * 2010-02-11 2013-02-04 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
IT1402974B1 (it) * 2010-11-30 2013-09-27 Menarini Int Operations Lu Sa Processo per la preparazione del nebivololo.
ITRM20110418A1 (it) 2011-08-02 2013-02-03 Menarini Int Operations Lu Sa Processo per la preparazione di epossidi quali intermedi per la sintesi del nebivololo.
WO2014111903A2 (en) 2013-01-21 2014-07-24 Cadila Pharmaceuticals Limited A process for the preparation of 6-fluoro-3,4-dihydro-2h-chromene- 2-carbaldehyde
EP2907809B1 (en) 2014-02-14 2018-08-22 Corden Pharma International GmbH Base-free process for the preparation of ketone intermediates usable for manufacture of nebivolol
EP2907810A1 (en) 2014-02-14 2015-08-19 Corden Pharma International GmbH A new method for producing nebivolol hydrochloride of high purity
DE102014107132A1 (de) 2014-05-20 2015-11-26 Corden Pharma International Gmbh Verfahren zur Herstellung von Epoxiden die in der Herstellung von Nebivolol und dessen Derivaten einsetzbar sind
PL3299364T3 (pl) 2015-05-19 2022-02-07 Zhejiang Ausun Pharmaceutical Co., Ltd. Sposób syntezy nebiwololu i jego związek pośredni
CN105085499B (zh) * 2015-08-07 2018-09-25 上海现代制药海门有限公司 盐酸奈必洛尔中间体混合物的结晶分离方法
ITUB20160227A1 (it) 2016-01-21 2017-07-21 Menarini Int Operations Luxembourg Sa Processo per la sintesi di intermedi di Nebivololo

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1337429C (en) * 1983-12-05 1995-10-24 Guy Rosalia Eugene Van Lommen Derivatives of 2,2'-iminobisethanol

Also Published As

Publication number Publication date
DE68903516C5 (de) 2017-07-13
EP0334429A1 (en) 1989-09-27
NZ228321A (en) 1991-02-26
IE62159B1 (en) 1994-12-28
NL950031I1 (pt) 1996-02-01
GR3006972T3 (pt) 1993-06-30
CA1337432C (en) 1995-10-24
AU621591B2 (en) 1992-03-19
DE68903516T2 (de) 1993-04-01
PT90095B (pt) 1994-11-30
LU88842I2 (fr) 1997-01-27
DK146289D0 (da) 1989-03-22
DE68903516D1 (de) 1992-12-24
CY1802A (en) 1995-02-17
ES2052881T3 (es) 1994-07-16
KR890014510A (ko) 1989-10-24
HU211539A9 (en) 1995-12-28
AU3074289A (en) 1989-09-28
DE19675037I1 (de) 2003-09-04
KR970011287B1 (ko) 1997-07-09
HK123594A (en) 1994-11-18
DK174422B1 (da) 2003-02-24
JPH0637487B2 (ja) 1994-05-18
IL89691A0 (en) 1989-09-28
DK146289A (da) 1989-09-24
NL950031I2 (nl) 1997-01-06
JPH01283220A (ja) 1989-11-14
IL89691A (en) 1994-04-12
IE890906L (en) 1989-09-23
ZA892179B (en) 1990-11-28
EP0334429B1 (en) 1992-11-19

Similar Documents

Publication Publication Date Title
PT90095A (pt) Processo para a preparacao de derivados de 2,2'-iminobisetanol destiandos a potenciacao dos efeitos de agentes redutores da pressao sanguinea
PT89705A (pt) Processo para a preparacao de 2', 3'-didesoxi-2', 2'-difluoronucleosidos
BR8904890A (pt) Processo para a preparacao de um produto
BR8904174A (pt) Derivados de 3-aril-pirrolidin-2,4-diona(s),processo para sua preparacao,composicoes inseticidas,processos para combater insetos e para a preparacao de composicoes,aplicacao,esteres e processo para sua preparacao
BR8902297A (pt) Processo para a preparacao de 1,1,1,2-tetrafluoretano
PT93785A (pt) Processo para a preparacao de derivados de 3-substituido-2-oxindole
PT91731A (pt) Processo para a preparacao de composicoes farmaceuticas contendo ciclosporinas
BR9100438A (pt) Derivados de halogenoalil azolita,processo para sua preparacao,composicoes microbicidas,aplicacao,processos para combater microorganismos e para a preparacao de composicoes
PT90708A (pt) Processo para a preparacao de derivados de benzopirano
PT87190A (pt) Processo para a preparacao de composicoes farmaceuticas para a reducao dos efeitos indesejaveis das beta-lactaminas
PT90748A (pt) Processo par a preparacao de 4-amino-3-carboxi-quinoleinas e - naftiridinas
PT89779A (pt) Processo para a preparacao de derivados da piperidina
PT89780A (pt) Processo para a preparacao de derivados da tetrahidroisoquinolina
PT89482A (pt) Processo para a preparacao de derivados de nucleosidos disesoxi-didesidro-carboxilico
PT89922A (pt) Processo para a preparacao de derivados da tiazolidenodiona
PT89570A (pt) Processo para a preparacao de novos compostos de 1,3-dicarbonilo ciclicos
BR9103036A (pt) Composto,formulacao farmaceutica e processo para a preparacao do composto
PT90888A (pt) Processo para a preparacao de composicoes farmaceuticas contendo prostaglandinas
PT90224A (pt) Processo para a preparacao de composicoes sinergicas contendo imazalilo
EE03878B1 (et) 5-O-desosaminüül-6-O-metüülerütronoliid A derivaadid, nende valmistamismeetod ja kasutamine bioaktiivsete ühendite valmistamiseks
BR8900175A (pt) Processo para a preparacao de um produto de ciclopolidiorganossiloxano
FI93106C (fi) Menetelmä lääkeaineina käyttökelpoisten 2-iminobentsotiatsoliinijohdannaisten valmistamiseksi
PT92365A (pt) Processo para a preparacao de (s)-alfa-etil-2-oxo-1-pirrolidinoacetamida
PT91027A (pt) Processo para a preparacao de derivados peptidicos
PT92539A (pt) Processo para a preparacao de derivados de anfotericina b

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940509

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19951130

NF3A Restitutio in integrum

Effective date: 19960328

MM4A Annulment/lapse due to non-payment of fees, searched and examined patent

Free format text: MAXIMUM VALIDITY LIMIT REACHED

Effective date: 20090509